NJADDC Translational Neuroscience Event

Date & Time

Wednesday, October 13, 2021, 10:00 a.m.-2:00 p.m.


Industry Sponsored




Sponsored by Commission on Science, Innovation and Technology (CSIT) & JLABS

Hosted by New Jersey Academic Drug Discovery Consortium

Image of Neurons

Hosted by the New Jersey Academic Drug Discovery Consortium, the Translational Neuroscience Event will feature two panel sessions to discuss "Advances in the Treatment of Alzheimer's Disease" and "CNS Models and Biomarkers."


Session 1: Advances in the Treatment of Alzheimer's Disease

Keynote Speaker

Samuel Gandy, Mount Sinai Professor of Alzheimer's Disease Research

Panel Discussion

Moderator: Mark Day, Adjunct Associate Professor, Neuroscience, Yale University


  • Luciano D'Adamio, Professor, Rutgers Biomedical and Health Sciences
  • Jim Hendrix, Chief Scientific Officer, LuMind Foundation
  • Tauseef Butt, President and CEO, Progenra

Session 2: CNS Models & Biomarkers

Keynote Speaker Mark Varney, Chief Scientific Officer, PsychoGenics
Panel Discussion

Moderator: Sam Kongsamut, Co-founder, Vice President Research & Development, Bryologyx and Strategic Advisor, ILSE


  • Koduvayur P. Subbalakshmi, Founding Director, Stevens Institute for Artificial Intelligence
  • Bob Nagele, Professor of Geriatrics, New Jersey Institute for Successful Aging, Rowan University School of Osteopathic Medicine
  • Johannes Weickenmeier, Assistant Professor, Stevens Institute of Technology
  • Karteek Kadimisetty, R&D Director, Life Sensors
  • William Hu, Chief, Division of Cognitive Neurology, Rutgers Robert Wood Johnson Medical School

Brought to you by: Institute for Life Science Entrepreneurship; Rutgers University; Stevens Institute of Technology; Princeton University; Rowan University